Meta-analysis reveals that patients with CKD and ESRD who have hypomagnesemia have a 32% higher risk for death from any cause.
A recently published report describes the case of a 62-year-old patient who experienced rare but serious central nervous system (CNS) side effects following the initiation of gabapentin therapy.
In a phase 3 trial, tenapanor, which reduces paracellular phosphate transport in the intestine, lowered elevated serum phosphorus in patients on hemodialysis.
In a small study of hemodialysis patients with secondary hyperparathyroidism, microwave ablation achieved higher rates of the recommended target levels of intact parathyroid hormone.
In a Finnish study, the cumulative risk for end-stage renal disease among patients with newly diagnosed with type 2 diabetes was less than 1% at 20 years.
Patients undergoing dialysis would like to be able to exercise to improve energy, strength
1,000 deaths of kidney failure patients each year in US may be attributable to seasonal influenza.
In a real-world study, patients’ preferences did not weigh heavily in clinicians’ decisions to initiate dialysis.
Two companion meta-analyses show that early changes in albuminuria can predict the risk for end-stage renal disease.
Elevated serum potassium levels increased the risk for end-stage renal disease by approximately 30%, independent of decline in estimated glomerular filtration rate.